Skip to main content
Clinical Trials/CTRI/2025/08/093917
CTRI/2025/08/093917Not yet recruitingPhase 2/3

Clinical evaluation of Vrishadi Niruha Kala Basti in Gridhrasi (Sciatica)

Dr Ranjana Nautiyal1 site in 1 country30 target enrollmentStarted: September 8, 2025Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Reducing pain, Symptoms relief (Toda, Stambha, Spandana, Tandra, Gaurava, Aruchi), Improving functional ability

Study Overview

Brief Summary

Gridhrasi is the most complex and prominent disease among 80 types of Nanatmaja vata vyadhis. It is characterised by radiating pain from the Lumbosacral region through the thigh, knee, calf and foot. the cardinal sign and symptoms of Gridhrasi are Ruka, Toda, Stambha, Spandana. In kaphanubandha Gridhrasi Tandra, Gaurav, Aruchi are also present.

In Sushruta Samhita VRISHADI NIRUHA BASTI is indicated in the management of Gridhrasi. In present study Kala Basti schedule is selected. 30 patients who were suffering from Gridhrasi and who fulfilling the diagnostic and inclusion criteria will be selected for the clinical study so here is an attempt to evaluate the efficacy of Basti in Gridhrasi under the topic "CLINICAL EVALUATION OF VRISHADI NIRUHA KALA BASTI IN GRIDHRASI (SCIATICA)"

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
20.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Presence of the classical sign and symptoms of Gridhrasi (Sciatica).
  • Patients fit for Basti procedure.
  • Patient with tenderness along the course of sciatic nerve.

Exclusion Criteria

  • Patients unfit for Basti procedure.
  • Patients with Uncontrolled Diabetes mellitus, Renal disorder, Cardiovascular disease.
  • Pregnant and lactating mother.
  • Diagnosed cases of Pott’s Spine and Lumbosacral malignancy.

Outcomes

Primary Outcomes

Reducing pain, Symptoms relief (Toda, Stambha, Spandana, Tandra, Gaurava, Aruchi), Improving functional ability

Time Frame: 3 wks

Secondary Outcomes

  • Changes in SLR angle, increase walking time(7 wks)

Investigators

Sponsor
Dr Ranjana Nautiyal
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Ranjana Nautiyal

Himalayiya Ayurvedic Pg Medical College and Hospital

Study Sites (1)

Loading locations...

Similar Trials